Gilteritinib, a highly potent FLT3 inhibitor, has demonstrated promising clinical outcomes in adults with relapsed/refractory (R/R) FLT3-mutated AML [111]
The pilot program is not for beneficiaries with type 2 diabetes, obstructive sleep apnea or MASH. Those enrollees and those prescribed GLP-1s to reduce the risk of heart attack, stroke or coronary bypass surgery are ineligible for the program and can get Medicare coverage of the drugs only through their Part D plan, CMS says
The right movement plan supports your metabolism, keeps your muscles toned, and helps you stay motivated
If youre on GLP-1 therapy , prioritize forms with better GI tolerance (malate, glycinate) and be cautious with citrate/oxide if youre already dealing with nausea, diarrhea, or stomach sensitivity
Metformin could potentially increase the GLP-1 concentration by increasing its secretion from L cells, and/or by reducing its breakdown by DPP4
Before anyone considers GLP-1 therapy at any dose let me be clear about who needs to avoid these medications: Personal or family history of medullary thyroid cancer or MEN-2 syndrome contraindicated History of pancreatitis may not be safe Severe gastroparesis these drugs will worsen it Pregnancy or active conception planning not recommended These are real medications with real side effects: nausea, vomiting, constipation, gallbladder problems